|

Claseprubart Clinical Trials

1 actively recruiting trial across 1 location

Also known as: DNTH103

Pipeline

Phase 3: 1

Top Sponsors

  • Dianthus Therapeutics1

Indications

  • Myasthenia Gravis, Generalized1
  • Cancer1

Fayetteville, North Carolina1 trial

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Cinical Study Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.